Overexpression of STAT4 mRNA was significantly associated with a favorable OS (HR =0.79 (0.64–0.98), P=0.035) (Figure 4A), RPS (HR =0.69 (0.62–0.77), P<0.001) for breast cancer patients. The gene discussed is STAT4; the disease is breast carcinoma.